• Home
  • Digital Health
  • Medi Whale
  • Home
  • All
  • Mediwhale
  • Medi Whale Inc. established a sales headquarter in Singapore
 
  • Home
  • Digital Health
  • Medi Whale
  • Home
  • All
  • Mediwhale
  • Medi Whale Inc. established a sales headquarter in Singapore
 
  • Home
  • All
  • Mediwhale
  • Medi Whale Inc. established a sales headquarter in Singapore
 

Medi Whale Inc. established a sales headquarter in Singapore

Medi Whale Inc. established a sales headquarter in Singapore

by Mediwhale / Wednesday, 05 December 2018 / Published in Mediwhale

Medi Whale Inc. announced on last 4th December that they are now starting the sales of ‘DrNoon’, a diagnostic solution of eye diseases using artificial intelligence(AI). They said that they have recently established a business headquarter in Singapore to support the sales in Southeast Asia. They are now supplementing their manpower for sales for hospitals in Thailand, Vietnam, and Indonesia.

DrNoon, developed by Medi Whale, an artificial intelligence software that makes a diagnosis about the patient’s eye condition based on the collection of over 100,000 eye diagnosis data. The diagnosis is made by analyzing the fundus photographs. It tells about lesions in eye vessels, macula, and optic nerves. The accuracy reached up to 95%. It can help diagnose diabetic retinopathy, which is a popular complication of diabetes.

The development of DrNoon is already finished. Medi Whale made a strategic decision to target Southeast Asian market first, where such diagnosis-supporting tool for diseases that needs knowledge of specialists would be even more powerful. In South Korea, it is going through its clinical trial for medical device approval early next year. They expect the commercialization to be possible in late 2019 in Korea.

Kevin Choi, CEO of Medi Whale, said that “We have already gone through a clinical trial on our own and now we are preparing for the clinical trial for medical device approval. Along with the medical device certification process going on, we are trying to look for demands for the solution, mainly including internal clinics and health checkup centers.”

“The cardiovascular disease diagnostic device will only cost about 10 USD per examination, which would supplement the preexisting, expensive computer tomography solution,” Kevin Choi said, “being devoted to finding a fast way for people to get healthy, we would like to support countries with weak medical infrastructure.”

What you can read next

Medi Whale is proceeding a prospective clinical trial in India
Medi Whale partnered with Siloam Eye Hospital
Medi Whale got a tech transfer from Yonsei Medical Center

You must be logged in to post a comment.

Beyond the Human Cognition

New intelligence for a human health

Recent Posts

  • Artificial intelligence (AI), Diagnosis of heart disease through retinal images

    The AI diagnostic device DrNoon captures and an...
  • Piquent, Mediwhale, Wayne Hills Ventures … Selected 15 startups to accompany the CES Seoul Pavilion in 2021

              The Seoul Digital Foundation held a &...
  • Medi Whale is proceeding a prospective clinical trial in India

    Medi Whale Inc. announced on the last 18th that...
  • Medi Whale got a tech transfer from Yonsei Medical Center

    Medi Whale Inc. got a tech transfer from Yonsei...
  • Medi Whale partnered with Siloam Eye Hospital

    On the last 17th, Medi Whale Inc. and Siloam Ey...

Archives

  • September 2020
  • July 2020
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • July 2018
  • June 2018
  • May 2018
  • March 2018
  • December 2017
  • October 2017
  • September 2017
  • May 2017
  • March 2017

Copyright ⓒ 2018. Mediwhale All rights reserved.

TOP